{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,11]],"date-time":"2024-05-11T11:16:35Z","timestamp":1715426195255},"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.endonu.2016.08.006","type":"journal-article","created":{"date-parts":[[2016,10,18]],"date-time":"2016-10-18T01:06:22Z","timestamp":1476752782000},"page":"569-570","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Interacci\u00f3n farmacol\u00f3gica de venlafaxina en el diagn\u00f3stico de feocromocitoma"],"prefix":"10.1016","volume":"63","author":[{"given":"Ana Bel\u00e9n","family":"Ma\u00f1as-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alicia","family":"Aragoneses-Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Matei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvie","family":"Ojeda-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Garc\u00eda-Durruti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.endonu.2016.08.006_bib0030","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc1101502","article-title":"Drugs and pheochromocytoma. Do\u0144t be fooled by every elevated metanephrine","volume":"364","author":"Neary","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.endonu.2016.08.006_bib0035","doi-asserted-by":"crossref","first-page":"2656","DOI":"10.1210\/jc.2002-030005","article-title":"Biochemical diagnosis of pheochromocytoma: How to distinguish true-from false-positive test results","volume":"88","author":"Eisenhofer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2016.08.006_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinbiochem.2016.06.004","article-title":"No influence of antihypertensive agents on plasma free metanephrines","author":"Osinga","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/j.endonu.2016.08.006_bib0045","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.endonu.2016.08.006_bib0050","doi-asserted-by":"crossref","first-page":"368","DOI":"10.4158\/EP14036.RA","article-title":"The Mount Sinai pathway for the management of pheochromocytoma","volume":"21","author":"Galati","year":"2015","journal-title":"Endocr Pract"}],"container-title":["Endocrinolog\u00eda y Nutrici\u00f3n"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092216301395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1575092216301395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T13:52:09Z","timestamp":1536328329000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1575092216301395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S1575092216301395"],"URL":"https:\/\/doi.org\/10.1016\/j.endonu.2016.08.006","relation":{},"ISSN":["1575-0922"],"issn-type":[{"value":"1575-0922","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interacci\u00f3n farmacol\u00f3gica de venlafaxina en el diagn\u00f3stico de feocromocitoma","name":"articletitle","label":"Article Title"},{"value":"Endocrinolog\u00eda y Nutrici\u00f3n","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.endonu.2016.08.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 SEEN. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}